Table 2 Bivariate analysis and full multivariate model with the 12 substitution classes using logistic regression for the 4,908 tumors with a somatic substitution prevalence of ≥1 sub/Mb.
From: Somatic substitution signature as an innovative tool in lung cancer diagnosis
Relative frequencies of substitutions in tumors | Bivariate Analyses | Full Mutivariate Model | ||
|---|---|---|---|---|
Odds ratio and 95% CI | p-value | Odds ratio and 95% CI | p-value | |
%CA >12 vs ≤12 | 14.44 [11.95; 17.46] | 0.001 | 4.86 [3.59; 6.58] | 0.001 |
%GT >13 vs ≤13 | 9.17 [7.66; 10.98] | <0.001 | 1.62 [1.2; 2.19] | 0.001 |
%CG ≥1 vs 0 | 0.45 [0.38; 0.54] | <0.001 | 1.52 [0.75; 3.06] | 0.24 |
%GC ≥1 vs 0 | 0.50 [0.42; 0.60] | <0.001 | 1.58 [0.78; 3.22] | 0.20 |
%CT | 0.84 [0.83; 0.85] | <0.001 | 0.91 [0.88; 0.93] | <0.001 |
%GA | 0.84 [0.83; 0.85] | <0.001 | 0.93 [0.91; 0.95] | <0.001 |
%AC | 0.67 [0.63; 0.72] | <0.001 | 0.82 [0.76; 0.90] | <0.001 |
%TG | 0.65 [0.61; 0.70] | <0.001 | 0.83 [0.76; 0.90] | <0.001 |
%AG >5 vs ≤5 | 0.23 [0.19; 0.28] | <0.001 | 0.43 [0.33; 0.58] | <0.001 |
%TC >5 vs ≤5 | 0.26 [0.21; 0.32] | <0.001 | 0.44 [0.33; 0.59] | <0.001 |
%AT >3 vs ≤3 | 1.84 [1.55; 2.17] | <0.001 | 0.99 [0.74; 1.33] | 0.96 |
%TA >3 vs ≤3 | 2.04 [1.72; 2.40] | <0.001 | 1.15 [0.86; 1.53] | 0.36 |